BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15077037)

  • 1. Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model.
    Kanmaz T; Fechner JJ; Torrealba J; Kim HT; Dong Y; Oberley TD; Schultz JM; Bloom DD; Katayama M; Dar W; Markovits J; Schuler W; Hu H; Hamawy MM; Knechtle SJ
    Transplantation; 2004 Mar; 77(6):914-20. PubMed ID: 15077037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of ABI793, a novel human anti-human CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation.
    Schuler W; Bigaud M; Brinkmann V; Di Padova F; Geisse S; Gram H; Hungerford V; Kleuser B; Kristofic C; Menninger K; Tees R; Wieczorek G; Wilt C; Wioland C; Zurini M
    Transplantation; 2004 Mar; 77(5):717-26. PubMed ID: 15021835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.
    Elster EA; Xu H; Tadaki DK; Montgomery S; Burkly LC; Berning JD; Baumgartner RE; Cruzata F; Marx R; Harlan DM; Kirk AD
    Transplantation; 2001 Nov; 72(9):1473-8. PubMed ID: 11707732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients.
    Cho CS; Burkly LC; Fechner JH; Kirk AD; Oberley TD; Dong Y; Brunner KG; Peters D; Tenhoor CN; Nadeau K; Yagci G; Ishido N; Schultz JM; Tsuchida M; Hamawy MM; Knechtle SJ
    Transplantation; 2001 Aug; 72(4):587-97. PubMed ID: 11544416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD40 therapy extends renal allograft survival in rhesus macaques.
    Pearson TC; Trambley J; Odom K; Anderson DC; Cowan S; Bray R; Lin A; Hollenbaugh D; Aruffo A; Siadak AW; Strobert E; Hennigar R; Larsen CP
    Transplantation; 2002 Oct; 74(7):933-40. PubMed ID: 12394833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates.
    Ringers J; Haanstra KG; Kroczek RA; Kliem K; Kuhn EM; Wubben J; Ossevoort MA; Volk HD; Jonker M
    Transplantation; 2002 Mar; 73(6):862-6. PubMed ID: 11923684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation.
    Montgomery SP; Xu H; Tadaki DK; Celniker A; Burkly LC; Berning JD; Cruzata F; Elster EA; Gray G; Kampen RL; Swanson SJ; Harlan DM; Kirk AD
    Transplantation; 2002 Nov; 74(10):1365-9. PubMed ID: 12451232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of CD154 at the time of donor-specific blood transfusion does not improve kidney graft survival in rhesus monkeys.
    Ringers J; Ossevoort M; Haanstra K; Kroczek R; Volk D; Jonker M
    Transplant Proc; 2001; 33(1-2):524. PubMed ID: 11266938
    [No Abstract]   [Full Text] [Related]  

  • 9. IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates.
    Preston EH; Xu H; Dhanireddy KK; Pearl JP; Leopardi FV; Starost MF; Hale DA; Kirk AD
    Am J Transplant; 2005 May; 5(5):1032-41. PubMed ID: 15816883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection.
    Torrealba JR; Fernandez LA; Kanmaz T; Oberley TD; Schultz JM; Brunner KG; Peters D; Fechner JH; Dong Y; Hu H; Hamawy MM; Knechtle SJ
    Transplantation; 2003 Aug; 76(3):524-30. PubMed ID: 12923438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies investigating pretransplant donor-specific blood transfusion, rapamycin, and the CD154-specific antibody IDEC-131 in a nonhuman primate model of skin allotransplantation.
    Xu H; Montgomery SP; Preston EH; Tadaki DK; Hale DA; Harlan DM; Kirk AD
    J Immunol; 2003 Mar; 170(5):2776-82. PubMed ID: 12594309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.
    Kirk AD; Harlan DM; Armstrong NN; Davis TA; Dong Y; Gray GS; Hong X; Thomas D; Fechner JH; Knechtle SJ
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8789-94. PubMed ID: 9238056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of humanized monoclonal antibody to rhesus CD11a in rhesus monkey cardiac allograft recipients.
    Poston RS; Robbins RC; Chan B; Simms P; Presta L; Jardieu P; Morris RE
    Transplantation; 2000 May; 69(10):2005-13. PubMed ID: 10852588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
    Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
    Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway.
    Ossevoort MA; Ringers J; Kuhn EM; Boon L; Lorré K; van den Hout Y; Bruijn JA; de Boer M; Jonker M; de Waele P
    Transplantation; 1999 Oct; 68(7):1010-8. PubMed ID: 10532543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel, blocking, Fc-silent anti-CD40 monoclonal antibody prolongs nonhuman primate renal allograft survival in the absence of B cell depletion.
    Cordoba F; Wieczorek G; Audet M; Roth L; Schneider MA; Kunkler A; Stuber N; Erard M; Ceci M; Baumgartner R; Apolloni R; Cattini A; Robert G; Ristig D; Munz J; Haeberli L; Grau R; Sickert D; Heusser C; Espie P; Bruns C; Patel D; Rush JS
    Am J Transplant; 2015 Nov; 15(11):2825-36. PubMed ID: 26139432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
    Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft survival in a rhesus renal transplant model after immunotoxin-mediated T-cell depletion is enhanced by mycophenolate and steroids.
    Fechner JH; Dong Y; Hong X; Brunner KG; Tsuchida M; Neville D; Scharff J; Lee F; Oberley TD; Peters D; Schultz JM; Manthei ER; Hamawy MM; Knechtle SJ
    Transplantation; 2001 Aug; 72(4):581-7. PubMed ID: 11544415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates.
    Kirk AD; Burkly LC; Batty DS; Baumgartner RE; Berning JD; Buchanan K; Fechner JH; Germond RL; Kampen RL; Patterson NB; Swanson SJ; Tadaki DK; TenHoor CN; White L; Knechtle SJ; Harlan DM
    Nat Med; 1999 Jun; 5(6):686-93. PubMed ID: 10371508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ASKP1240 combined with tacrolimus or mycophenolate mofetil on renal allograft survival in Cynomolgus monkeys.
    Song L; Ma A; Dun H; Hu Y; Zeng L; Bai J; Zhang G; Kinugasa F; Sudo Y; Miyao Y; Okimura K; Miura T; Daloze P; Chen H
    Transplantation; 2014 Aug; 98(3):267-76. PubMed ID: 24992357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.